162 related articles for article (PubMed ID: 27532105)
1. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.
Jiang H; Liu W; Zhan SK; Pan YX; Bian LG; Sun B; Sun QF; Pan SJ
PLoS One; 2016; 11(8):e0161017. PubMed ID: 27532105
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo.
Chen L; Chen Q; Deng G; Kuang S; Lian J; Wang M; Zhu H
Biochem Biophys Res Commun; 2016 Nov; 480(4):515-521. PubMed ID: 27751856
[TBL] [Abstract][Full Text] [Related]
3. GSK621 activates AMPK signaling to inhibit LPS-induced TNFα production.
Wu YH; Li Q; Li P; Liu B
Biochem Biophys Res Commun; 2016 Nov; 480(3):289-295. PubMed ID: 27712936
[TBL] [Abstract][Full Text] [Related]
4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
5. Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts.
Liu W; Mao L; Ji F; Chen F; Hao Y; Liu G
Oncotarget; 2017 Feb; 8(6):10543-10552. PubMed ID: 28060740
[TBL] [Abstract][Full Text] [Related]
6. GSK621 attenuates oxygen glucose deprivation/re-oxygenation-induced myocardial cell injury via AMPK-dependent signaling.
Ting-Ting L; Yuan G; Jun L; Dan X; Hong-Bo T
Biochem Biophys Res Commun; 2019 Jun; 514(3):826-834. PubMed ID: 31079918
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
8. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.
Pan SJ; Wu YB; Cai S; Pan YX; Liu W; Bian LG; Sun B; Sun QF
Biochem Biophys Res Commun; 2015 Mar; 458(3):476-482. PubMed ID: 25680464
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.
Zhang WB; Wang Z; Shu F; Jin YH; Liu HY; Wang QJ; Yang Y
J Biol Chem; 2010 Dec; 285(52):40461-71. PubMed ID: 20880848
[TBL] [Abstract][Full Text] [Related]
12. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.
Sujobert P; Poulain L; Paubelle E; Zylbersztejn F; Grenier A; Lambert M; Townsend EC; Brusq JM; Nicodeme E; Decrooqc J; Nepstad I; Green AS; Mondesir J; Hospital MA; Jacque N; Christodoulou A; Desouza TA; Hermine O; Foretz M; Viollet B; Lacombe C; Mayeux P; Weinstock DM; Moura IC; Bouscary D; Tamburini J
Cell Rep; 2015 Jun; 11(9):1446-57. PubMed ID: 26004183
[TBL] [Abstract][Full Text] [Related]
13. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
Wang N; Zhang Q; Luo L; Ning B; Fang Y
J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
[TBL] [Abstract][Full Text] [Related]
14. DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide.
Zhao M; Tan B; Dai X; Shao Y; He Q; Yang B; Wang J; Weng Q
Eur J Pharmacol; 2019 Nov; 863():172665. PubMed ID: 31542479
[TBL] [Abstract][Full Text] [Related]
15. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
16. Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells.
Chu PM; Chen LH; Chen MT; Ma HI; Su TL; Hsieh PC; Chien CS; Jiang BH; Chen YC; Lin YH; Shih YH; Tu PH; Chiou SH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):621-33. PubMed ID: 21947203
[TBL] [Abstract][Full Text] [Related]
17. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis.
Wang B; Wang XB; Chen LY; Huang L; Dong RZ
Biochem Biophys Res Commun; 2013 Jul; 437(1):1-6. PubMed ID: 23743198
[TBL] [Abstract][Full Text] [Related]
18. TRPC5‑induced autophagy promotes the TMZ‑resistance of glioma cells via the CAMMKβ/AMPKα/mTOR pathway.
Zou Y; Chen M; Zhang S; Miao Z; Wang J; Lu X; Zhao X
Oncol Rep; 2019 Jun; 41(6):3413-3423. PubMed ID: 30942446
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma.
Zou Y; Wang Q; Li B; Xie B; Wang W
Mol Med Rep; 2014 Jul; 10(1):411-6. PubMed ID: 24737504
[TBL] [Abstract][Full Text] [Related]
20. Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway.
Zhao W; Peng F; Shu M; Liu H; Hou X; Wang X; Ye J; Zhao B; Wang K; Zhong C; Xue L; Gao M; Liu Y; Zhao S
Cell Physiol Biochem; 2017; 44(4):1381-1395. PubMed ID: 29186708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
